Literature DB >> 26217598

Public perception of risk-reducing salpingectomy for preventing ovarian cancer.

Jun Hyeok Kang1, Se Hyun Nam1, Taejong Song1, Woo Young Kim1, Kyo Won Lee1, Kye Hyun Kim1.   

Abstract

OBJECTIVE: The fallopian tube is considered as the site of origin of serous ovarian cancer, and risk-reducing salpingectomy (RRS) has been proposed as a new and safe strategy for preventing ovarian cancer. However, little is known about the public perception of RRS.
METHODS: We performed a questionnaire survey of 100 healthy female volunteers in November 2014. Questionnaire for this survey included questions on demographics, medical history, knowledge of and belief about RRS, and barrier to its application.
RESULTS: Among 100 respondents, 71% did not realize the seriousness of ovarian cancer, 79% were unaware of the fact that salpinx was the origin of ovarian cancer, and 87% stated that they had never heard of RRS as a preventive method for ovarian cancer. Also, 98% of respondents replied that they had the right to be informed about RRS and the choice given. The respondents' fears about RRS included increased risk of surgical complications (68%), no benefit (8%), and increased surgical costs (3%).
CONCLUSION: Most general women were unaware of RRS as a method for preventing ovarian cancer in women at average risk. Therefore, physicians should discuss RRS with patients and consider this procedure at the time of abdominal or pelvic surgery.

Entities:  

Keywords:  Data collection; Ovarian neoplasms; Public perception; Risk-reducing salpingectomy

Year:  2015        PMID: 26217598      PMCID: PMC4515477          DOI: 10.5468/ogs.2015.58.4.284

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  18 in total

1.  Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament

Authors: 
Journal:  Arch Pathol Lab Med       Date:  2000-03       Impact factor: 5.534

2.  Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Duk Hyoung Lee; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

3.  Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.

Authors:  A-B Skytte; A-M Gerdes; M K Andersen; L Sunde; K Brøndum-Nielsen; M Waldstrøm; S Kølvraa; D Crüger
Journal:  Clin Genet       Date:  2010-01-06       Impact factor: 4.438

Review 4.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

5.  Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Rayna K Matsuno; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2010-06-29       Impact factor: 5.482

6.  Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors:  K A Rosenblatt; D B Thomas
Journal:  Int J Epidemiol       Date:  1993-04       Impact factor: 7.196

7.  Factors affecting the association of oral contraceptives and ovarian cancer.

Authors:  D W Cramer; G B Hutchison; W R Welch; R E Scully; R C Knapp
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

8.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

Review 9.  Prognostic factors in ovarian cancer.

Authors:  M L Friedlander
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

10.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

View more
  1 in total

1.  Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review.

Authors:  Ying Chen; Hui Du; Lewen Bao; Wenxin Liu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.